Lymphocyte resistance to lysophosphatidylcholine mediated apoptosis in atherosclerosis

Atherosclerosis

Volumn 190, Issue 1, 2007, Pages 73-83

  Zurgil, Naomi ^a   Afrimzon, Elena ^a   Shafran, Yana ^a   Shovman, Ora ^b   Gilburd, Boris ^b   Brikman, Haim ^b   Shoenfeld, Yehuda ^b   Deutsch, Mordechai ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Apoptosis; Atherosclerosis; Leukocytes; Oxygen radicals; Signal transduction

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; PHYTOHEMAGGLUTININ; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL ISOLATION; CELLULAR DISTRIBUTION; CHRONOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; DOSE RESPONSE; FEMALE; HUMAN; LYMPHOCYTE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA, UNSTABLE; ANNEXIN A5; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE; CELL SIZE; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; LYMPHOCYTES; LYSOPHOSPHATIDYLCHOLINES; MALE; MIDDLE AGED; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STAINING AND LABELING;

EID: 33845536417     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.02.013     Document Type: Article

References (36)

1. Littlewood T.D., and Bennett M.R. Apoptotic cell death in atherosclerosis. Curr Opin Lipidol 14 (2003) 469-475
2. Guevara N.V., Chen K.H., and Chan L. Apoptosis in atherosclerosis: pathological and pharmacological implications. Pharmacol Res 44 (2001) 59-71
3. Hansson G., Holm J., and Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 135 (1989) 169-175
4. Stemme S., Faber B., Holm J., et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low-density lipoprotein. Proc Natl Acad Sci USA 92 (1995) 3893-3897
5. Roselaar S., Scholfeld G., and Daugherry A. Enhanced development of atherosclerosis in cholesterol fed rabbits by suppression of cell mediated immunity. J Clin Invest 96 (1995) 1389-1394
6. de Boer O.J., Hirsch F., van der Wal A.C., et al. Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. Atherosclerosis 133 (1997) 227-234
7. Zurgil N., Levy Y., Deutsch M., et al. Reactivity of peripheral blood lymphocytes to oxidized low-density lipoprotein: a novel system to estimate atherosclerosis employing the Cellscan. Clin Cardiol 22 (1999) 526-532
8. Witztum J.L. The role of oxidized LDL in atherosclerosis. Adv Exp Med Biol 285 (1991) 353-365 [review]
9. Hurt-Camejo E., and Camejo G. Potential involvement of type II phospholipase A2 in atherosclerosis. Atherosclerosis 132 (1997) 1-8
10. Steinberg D., Parthasarathy S., Carew T.E., et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320 (1989) 915-924
11. Zurgil N., Sunray M., Shafran Y., et al. A novel approach for on line monitoring of apoptotic cell shrinkage in individual live lymphocytes. J Immunol Methods 281 (2003) 37-49
12. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
13. Kume N., Ochi H., Nishi E., et al. Involvement of protein kinase C-independent mechanisms in endothelial ICAM-1 up-regulation by lysophosphatidylcholine. Ann NY Acad Sci 748 (1995) 541-542
14. Takahara N., Kashiwagi A., Maegawa H., and Shigeta Y. Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. Metabolism 45 (1996) 559-564
15. Kita T., Kume N., Yokode M., et al. Oxidized-LDL and atherosclerosis. Role of LOX-1. Ann NY Acad Sci 902 (2000) 95-100
16. Lauber K., Bohn E., Krober S.M., et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113 (2003) 717-730
17. Kabarowski J.H.S., Zhu K., Le L.Q., et al. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 293 (2001) 702-705
18. Rikitake Y., Hirata K., Yamashita T., et al. Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 22 (2002) 2049-2053
19. Lin P., and Ye R.D. The lysophospholipid receptor G2A activates a specific combination of G proteins and promotes apoptosis. J Biol Chem 278 (2003) 14379-14386
20. Hsieh C.C., Yen M.H., Liu H.W., and Lau Y.T. Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL. Atherosclerosis 151 (2000) 481-491
21. Takahashi M., Okazaki H., Ogata Y., et al. Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism. Atherosclerosis 161 (2002) 387-394
22. Jostarndt K., Gellert N., Rubic T., et al. Dissociation of apoptosis induction and CD36 upregulation by enzymatically modified low-density lipoprotein in monocytic cells. Biochem Biophys Res Commun 290 (2002) 988-993
23. Alcouffe J., Caspar-Bauguil S., Garcia V., et al. Oxidized low-density lipoproteins induce apoptosis in PHA-activated peripheral blood mononuclear cells and in the Jurkat T-cell line. J Lipid Res 40 (1999) 1200-1210
24. Kurosaka K., Takahashi M., Watanabe N., and Kobayashi Y. Silent cleanup of very early apoptotic cells by macrophages. J Immunol 171 (2003) 4672-4679
25. Langheinrich A.C., and Bohle R.M. Atherosclerosis: humoral and cellular factors of inflammation. Virchows Arch 446 (2005) 101-111
26. Hallenbeck J.M., Hansson G.K., and Becker K.J. Immunology of ischemic vascular disease: plaque to attack. Trends Immunol 26 (2005) 550-556
27. Weyand C.M., Goronzy J.J., Liuzzo G., et al. T-cell immunity in acute coronary syndromes. Mayo Clin Proc 76 (2001) 1011-1020
28. Liuzzo G., Goronzy J.J., Yang H., et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 102 (2000) 2883-2888
29. Yamakawa T., Tanaka S., Yamakawa Y., et al. Lysophosphatidylcholine activates extracellular signal-regulated kinases 1/2 through reactive oxygen species in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 22 (2002) 752-758
30. Inoue N., Takeshita S., Gao D., et al. Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis 155 (2001) 45-52
31. Matsubara M., and Hasegawa K. Benidipine, a dihydropyridine-calcium channel blocker, prevents lysophosphatidylcholine-induced injury and reactive oxygen species production in human aortic endothelial cells. Atherosclerosis 178 January (1) (2005) 57-66
32. Goonesinghe A., Mundy E.S., Smith M., Khosravi-Far R., Martinou J.C., and Esposti M.D. Pro-apoptotic Bid induces membrane perturbation by inserting selected lysolipids into the bilayer. Biochem J 387 Pt 1 (2005) 109-118
33. Wang A.Y., Bobryshev Y.V., Cherian S.M., et al. Expression of apoptosis related proteins and structural features of cell death in explanted aortocoronary saphenous vein bypass grafts. Cardiovasc Surg 9 (2001) 319-328
34. Hata S., Fukuo K., Morimoto S., et al. Vascular smooth muscle maintains the levels of bcl-2 in endothelial cells. Atherosclerosis 154 (2001) 309-316
35. Prokazova N.V., Zvezdina N.D., and Korotaeva A.A. Effect of Lysophosphatidylcholine on transmembrane signal transduction. Biochemistry (Mosc) 63 (1998) 31-37
36. Zuppini A., Groenendyk J., Cormack L.A., et al. Calnexin deficiency and endoplasmic reticulum stress-induced apoptosis. Biochemistry 41 (2002) 2850-2858